PDE4A and myeloid sarcoma: At the genetic level, COVID-19 hospitalization and MS share five risk genes within two loci, including TNFAIP8, HSD17B4, CDC37, PDE4A, and KEAP1, which may mediate the association between MS and COVID-19 [44].